Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Senate Finance Chair Ron Wyden has demanded information on the tax practices of Pfizer Inc., expanding his panel’s probe into the profit-shifting practices of US pharmaceutical companies. Wyden's inquiry focuses on Pfizer's use of tax havens and a questionable grant in Puerto Rico that partially exempts the company from most local taxes. The probe aims to scrutinize how Pfizer and potentially other pharmaceutical firms shift profits out of the United States to reduce their tax liabilities. Wyden has also addressed a letter to Pfizer's CEO as part of this inquiry.
I am going to go out on a limb and predict that Senator Wyden will find that Pfizer has aggressively shifted profits out of the United States. (domestic profit in 21 and 22 was likely tied to the vaccine) 1/2 https://t.co/lovFzZnxrw https://t.co/Nnu0sxr1JG
Love to see it: @RonWyden @SenateFinance have some tough questions for Pfizer over their profit shifting to tax havens, as well as a questionable "grant" in #PuertoRico that partially exempts it from most local taxes https://t.co/zQlQlNHVz5
In pharma tax probe, Wyden puts Pfizer in hot seat with CEO letter https://t.co/WgoBWQiT83
